- Details
- Hits: 53
WHAT IS CONTACT TRACING? | FEB 22, 2021
- Details
- Hits: 56
KonsulTayo sa ating Primary Care Providers | Feb 22, 2021
- Details
- Hits: 45
BAKUNATION SA CEBU CITY | FEB 22, 2021
- Details
- Hits: 23
MOBILE BLOOD DONATION | FEB 22, 2021
- Details
- Hits: 49
This assessment followed the HTAC evaluation framework to assess COVID-19 Vaccine (ChAdOx1-S [recombinant]) (COVID-19 Vaccine AstraZeneca) which consists of the following criteria: (1) responsiveness to magnitude and severity; (2) clinical efficacy and safety; (3) affordability and viability; (4) household financial impact; (5) social impact; and (6) responsiveness to equity.
Direct access link (Evidence Summary on COVID-19 Vaccine (ChAdOx1-S [recombinant]) [COVID-19 Vaccine AstraZeneca]): http://bit.ly/ESAstraZenecaC19